real-time news and commentary for investors
Monday, Aug 5
Hansen Medical enrolls the first patients robotic catheter trial
- Hansen Medical (HNSN +11%) pops after announcing the first patients have been enrolled in its Artisan-AF Trial, a test of the company's Artisan family of Control Catheters with its Sensei X Robotic Catheter System for the treatment of atrial fibrillation.
- The Company announced in May that it had received conditional approval of the new study design from the FDA, and is targeting the enrollment of as few as 125 subjects at up to 14 investigational sites.
- It plans to use the data derived from the study to obtain approval for a broader label claim for use of its control catheters in tandem with its Sensei X Robotic Catheter System in atrial fibrillation procedures.